Overview

Drug Repurposing for Improving the Therapeutic Outcome in Multiple Sclerosis Patients

Status:
Not yet recruiting
Trial end date:
2023-03-28
Target enrollment:
Participant gender:
Summary
This study aims to evaluate the effect of Metformin as add- on therapy for improving the outcome in RRMS patients.
Phase:
Phase 2
Details
Lead Sponsor:
German University in Cairo
Treatments:
Interferon beta-1a
Interferon-beta
Interferons
Metformin